{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/jeffrey-a-meyerhardt/", "hostname": "dana-farber.org", "description": "Jeffrey A. Meyerhardt, MD, MPH, FASCO - Medical Oncology. Dr. Meyerhardt received his MD from Yale School of Medicine in 1997. He completed a residency in internal medicine at Beth Israel Deaconness Medical Center, in Boston, followed by a medical oncology fellowship at DFCI. He joined the Gastrointestinal Cancer Center at DFCI in 2002..", "sitename": "Jeffrey A. Meyerhardt, MD, MPH, FASCO - Dana-Farber Cancer Institute", "date": "2015-03-03", "cleaned_text": "Assessment and Prognostic Value of Inflammatory Biomarkers in Patients With Colon Oncol. 2023 08 01; 9(8):1153-1154. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37318802) Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer. Cancer Epidemiol Biomarkers Prev. 2023 Jul 14. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37450841) Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance). Clin Cancer Res. 2023 14; 29(14):2621-2630. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37289007) Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal Jun 12; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37367904) Bayesian risk prediction model for colorectal cancer mortality integration of clinicopathologic and genomic Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023 Jul 27; 389(4):322-334. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37272534) Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048). J Clin Oncol. 2023 07 20; 41(21):3724-3734. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37270691) Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37308125) and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance). Br J Cancer. 2023 08; 129(2):283-290. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37179438) Phase Ib and Expansion 13; 14(1):2102. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37055393) Flavonoid intake and survival after diagnosis of colorectal cancer: a prospective study in 2 US cohorts. Am J Clin Nutr. 2023 06; 117(6):1121-1129. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37011765) Association between physical activity and the time course of cancer recurrence in stage III colon cancer. Br J Sports Med. 2023 Aug; 57(15):965-971. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36878665) Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer. JAMA Oncol. assays for detection of antibodies in patient samples. Cell Rep Methods. 2023 Mar 27; 3(3):100421. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37056371) Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages. Support Care Cancer. 2023 Feb 10; 31(3):155. View 2023 29(2):458-466. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36702949) Prognostic role of detailed and tumor molecular features: analyses of 13,101 colorectal cancer patients including 03; 58(3):229-245. View in: 2023 01; 7:e2200342. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36634297) Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of randomized Oxaliplatin-Induced Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG clinical trial factors: an Prognostic role of inflammatory colorectal cancer and in strata of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. J Clin Oncol. 2023 02 01; 41(4):803-815. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36306483) medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study. Br J Cancer. 2022 11; 127(11):1974-1982. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36138074) Cancer Survivors' Perspectives of Virtual Yoga for Chronic Chemotherapy-Induced Peripheral Neuropathy Pain During the COVID-19 Pandemic. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35834226) Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 01 15; 152(2):123-136. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35904874) Physical Activity in [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35927535) Healthy and unhealthy plant-based diets in relation to the incidence of colorectal cancer overall and by molecular in or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 Studies. Gastroenterology. 2022 10; 163(4):862-874. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35760086) Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from sugar consumption and colorectal cancer incidence and mortality according to adults with metastatic gastrointestinal cancer: a pilot and feasibility study. Exerc Med. 2022; 8(2):e001353. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35722047) The association of abdominal adiposity with premature discontinuation of postoperative chemotherapy in Nutr. 2022 07; 41(7):1600-1604. View in: testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center. PLoS One. 2022; 17(4):e0266791. View in: in: Desmoplastic Reaction, Cancer. Front Immunol. 2022; 13:840198. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35392092) American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022 Metabolite Profiles of Red Meat, Poultry, and Fish Consumption, and Their Associations with Colorectal Cancer Risk. Nutrients. 2022 Feb 25; 14(5). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35267954) Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages. Support Care Cancer. 2022 May; 30(5):4557-4564. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35119520) Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer. JAMA Netw Open. 2022 02 01; 5(2):e220145. View in: and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB Cancer Patients and Prognosis According to Histopathologic Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study. Am J Gastroenterol. 2022 01 01; 117(1):158-166. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34730560) Adjuvant Therapy of NK and NKT-like Cells via Multimarker Analysis deposits in colorectal cancer: Towards a next TNM Treat Rev. 2022 Feb; 103:102325. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34954486) Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers. JAMA Netw tissue radiodensity is survival cancer. Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. behavior and risk of digestive system cancers: a prospective cohort study. Am 2021 11 08; 114(5):1612-1624. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34293086) The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute. J Natl Cancer Inst. 2021 11 02; 113(11):1453-1459. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32959883) Unrestrained eating behavior and risk A study. Clin Nutr. 2021 11; 40(11):5419-5429. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34524631) Association 2021; tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34293461) artificially sweetened beverage and sugar intake and colorectal cancer survival. Br J Cancer. 2021 09; 125(7):1016-1024. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34267328) Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study. J 2021 07 01; 113(7):841-851. View in: and Cancer Discov. 2021 10; 11(10):2446-2455. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34140290) The Early Impact of the IDEA Collaboration Results: How the Results Changed Prescribing 08; 5(4). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34350375) Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men. Int J Cancer. 2021 10 15; 149(8):1529-1535. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34028016) Randomized Phase II of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB (Alliance) Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer products intake and colorectal cancer survival in US males and females. Am Nutr. 2021 06 01; 113(6):1636-1646. View in: changes in body composition in colorectal cancer: a retrospective cohort study. adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut. 2021 Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis. Cancers (Basel). 2021 Apr 22; 13(9). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33922024) Race, Income, and in Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33821899) Determining the immune cells and their spatial distribution in the colorectal cancer microenvironment. J Immunother Cancer. 2021 04; 9(4). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33931472) Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women. Ann Oncol. 2021 06; 32(6):778-786. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33812017) Simple Sugar and Sugar-Sweetened Beverage Intake During Adolescence and Risk of Colorectal Cancer Precursors. Gastroenterology. 2021 Among JAMA Oncol. Type 2 Inflammatory and Insulinemic Potential of Diet and Lifestyle with Risk of Hepatocellular Colorectal Cancers intake during adolescence and risk of colorectal adenoma later in life. Br J Women. Hepatology. 2021 01; 73(1):175-185. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32222996) Dietary intake of branched-chain amino acids and survival after colorectal cancer diagnosis. Int J Cancer. 2020 Dec 19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33341092) Recruitment strategies and design considerations in a trial of resistance training to prevent dose-limiting toxicities in colon cancer patients undergoing 2021 02; 101:106242. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33301991) Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 2020 12; 21(12):1620-1629. Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. Cancers (Basel). 2020 Nov 20; 12(11). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33233566) Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer. JAMA Oncol. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32940631) Moving through cancer: Setting the agenda to make exercise standard in oncology practice. Cancer. 2021 02 01; 127(3):476-484. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33090477) Modified 02; Risk Factors and of Colorectal Cancer According Major Molecular 01; 9(1):8-19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33023967) Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. JAMA Netw Open. 2020 10 01; 3(10):e2023500. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33125497) Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32805015) Anxiety, Depression, and Colorectal Cancer Survival: Results from Two Prospective Cohorts. J Clin Med. 2020 Sep 30; 9(10). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33007946) Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. Cancer to JNCI Cancer Spectr. 2020 Dec; 4(6):pkaa068. Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: Randomized survival outcomes among colorectal cancer patients. BMC Cancer. 2020 Aug 27; 20(1):817. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32854644) Tumour budding, poorly differentiated Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance). Cancer Epidemiol Biomarkers Prev. 2020 08; 29(8):1692-1695. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32499312) Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections. Clin Cancer Res. 2020 08 15; 26(16):4326-4338. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32439699) Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction. JNCI Cancer Spectr. 2020 Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients. J Cachexia Sarcopenia Muscle. 2020 10; 11(5):1258-1269. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32314543) Physical Activity and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Cancer Prev Res (Phila). 2020 08; 13(8):707-714. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32312712) The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer. J Natl Cancer Inst. 2020 04 01; 112(4):377-383. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31355882) Body Mass Index and exercise oncology clinical pathway: Screening and referral for personalized interventions. Cancer. 2020 06 15; 126(12):2750-2758. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32212338) Guidelines for time-to-event adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. Eur J Cancer. 2020 130:63-71. Metabolic Res. 2020 06; 18(6):883-890. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32165453) An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer. Br J Cancer. 2020 04; 122(9):1367-1377. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32157241) No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2020 04 01; 38(10):1081. View status Pathol. 2020 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31880318) activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 06; 72(6):1062-1069. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31954204) Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Pilot Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical Oncol. 2020 Jan 01; 6(1):108-115. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31750855) Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women. Am J Gastroenterol. 2019 12; 114(12):1870-1877. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31688024) Randomized Phase Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Feb; 4(1):pkz096. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32090192) Dietary Intake of Branched-Chain Amino Acids and Risk of Colorectal Cancer. Cancer Prev Res (Phila). 2020 01; 13(1):65-72. Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced 3 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31486832) Night-Shift Duration and Risk of Colorectal Cancer to IRS1 and IRS2 View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32259016) Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 15; 25(24):7497-7505. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31548349) Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer Epidemiol Biomarkers with colorectal cancer: role of computed tomography texture analysis 26(13):4489-4497. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31418130) and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study. BMJ Open. 2019 08 15; 9(8):e025888. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31420381) Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group Clin Oncol. 2019 10 10; 37(29):2620-2631. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31408415) Body Composition and Cardiovascular Events in Patients With Colorectal Cancer: A Population-Based Retrospective Cohort 01; 5(7):967-972. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31095251) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31236958) A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. Int J Cancer. 2020 03 01; 146(5):1241-1249. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31116416) Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults. JAMA Oncol. 2019 Jun 01; 5(6):879-886. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30789662) Physical activity during adolescence and risk of colorectal adenoma later in life: results from the Nurses' Health Study II. Br J Cancer. 2019 07; 121(1):86-94. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31114018) Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer. Cancer Causes Control. 2019 Jul; 30(7):757-765. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31104167) Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:226-235. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31099666) A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev Res (Phila). 2019 06; 12(6):367-374. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31040153) Duration Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline. D3 Supplementation Survival Among With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized 09; 321(14):1370-1379. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30964527) Calcium intake and colon cancer risk subtypes by tumor molecular characteristics. Cancer Causes Control. 2019 Jun; 30(6):637-649. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30963391) Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233. 01; 125(13):2213-2221. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30913304) Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30866859) Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Hepatology. 2019 mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. Eur J Cancer. 2019 04; 111:82-93. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30826660) The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30850836) and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells. Cancer Prev Res (Phila). 2019 05; 12(5):283-294. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30760501) Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). J in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30726946) Low-Carbohydrate Diet Score and Macronutrient Intake in Relation to Survival After Colorectal Cancer Diagnosis. JNCI Cancer [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30734025) Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance). Int J Cancer. 2019 07 15; 145(2):380-389. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30623420) Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells. JNCI Cancer Spectr. 2018 Oct; 2(4):pky058. Risk Colorectal Sub-Classified by Tumor-Infiltrating T Cells. J 2019 01 01; 111(1):42-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30312431) Calcium Intake and Survival after Cancer Diagnosis. Cancer Res. 2019 03 15; 25(6):1980-1988. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30545821) Association Between Aspirin Use of Hepatocellular JAMA Oncol. 2018 12 01; Non-alcoholic fatty liver disease and colorectal cancer survival. Cancer Causes Control. 2019 Feb; 30(2):165-168. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30443695) The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol. 2018 12; 188(12):2839-2852. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30243655) to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res. 2018 11; 6(11):1327-1336. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30228205) Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. Eur J Cancer. 2018 11; 103:98-107. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30219720) Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30038051) Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance). PLoS Advanced to Medicine. Cancer Discov. 2018 09; 8(9):1096-1111. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29903880) Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29710284) Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 Muscle radiodensity and mortality in patients with colorectal cancer. Cancer. 2018 07 15; 124(14):3008-3015. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29797673) The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III a 08; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29766660) The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer? Ann Oncol. 2018 05 01; 29(5):1099-1107. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29438451) of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29632055) Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. N Engl J Med. 2018 Mar 29; 378(13):1177-1188. View metabolic comorbidities, and risk hepatocellular carcinoma: from two cohort studies. Hepatology. 2018 05; 67(5):1797-1806. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29152763) TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Polyunsaturated Fatty Acid Intake after Colon Cancer and Survival: CALGB 89803 Oncol. 2018 Jan 01; 4(1):71-79. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29098294) Association Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From 12 01; 3(12):e172319. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28796857) Psychological symptoms and subsequent healthy lifestyle after a colorectal cancer diagnosis. Health Psychol. 2018 03; 37(3):207-217. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29154605) Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality. Gastroenterology. 2018 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29158191) Adjuvant Cisplatin, Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Results calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study. Int J Cancer. 2017 12 15; 141(12):2471-2479. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28856682) Aspirin exerts Oncotarget. 2017 Oct 20; 8(50):87379-87389. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29152088) Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 01; 9(1):24-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28917648) Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28881381) Influence of dietary insulin scores on survival in colorectal cancer patients. Br J Cancer. 2017 Sep 26; 117(7):1079-1087. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28817837) Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer. Jul 27; 17(1):505. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28750659) Effect of home-based exercise intervention on fasting insulin and Adipocytokines in colorectal cancer survivors: a 11; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28987237) Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut. 2018 08; 67(8):1475-1483. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28676564) Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28632865) Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017 Jun 01; 28(6):1359-1367. Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol. 2017 05; 32(5):393-407. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28510098) Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28489507) Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. Oncologist. and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer. 2017 06 15; 140(12):2648-2656. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28268248) Cancer Susceptibility Colorectal Clin Oncol. 2017 Apr 01; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28135145) Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; and colorectal cancer risk: Results from the Nurses' Health Study. Int J Cancer. 2017 Feb 01; 140(3):646-652. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27778343) Obesity and Energy Balance in GI Cancer. J 2016 Nov 03; 7(11):e200. View in: Obesity, and Patients With Colorectal Cancer. J View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27760322) MicroRNA let-7, T Cells, and in Cancer Immunol Res. 2016 11; 4(11):927-935. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27737877) Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams. JAMA methylation level and colorectal cancer location in relation to patient survival. Oncotarget. 2016 23; 7(34):55098-55109. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27391152) fatty radiation therapy with celecoxib for patients with locally advanced esophageal cancer. BMC Cancer. 2016 07 13; 16:468. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27412386) Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27121247) Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer. 2016 08 15; 139(4):854-68. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27037951) Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications. Cancer J. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27341603) Genomic Correlates of Apr 26; 15(4):857-865. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27149842) Soluble tumour necrosis factor receptor type II and survival in colorectal cancer. Br J Cancer. 2016 04 Colorectal Patient Survival. Clin Cancer Res. 2016 08 01; 22(15):3841-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26957558) Cardiopulmonary fitness, adiponectin, chemerin associated fasting insulin level in colorectal cancer patients. Support Care Cancer. 2016 07; 24(7):2927-35. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26847448) Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. 23(3):908-17. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26577117) Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer. Clin Cancer Res. 2016 Mar 15; 22(6):1489-98. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26490308) What should we tell our patients with colorectal cancer about diet, supplements, and one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin in: Gut. 2016 12; 65(12):1973-1980. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26311717) Television watching and colorectal cancer survival in men. Cancer Causes Control. 2015 Oct; 26(10):1467-76. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26293240) Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26282659) CT predictors of overall survival at initial diagnosis in patients with stage IV colorectal cancer. Abdom Imaging. 2015 Jun; 40(5):1170-6. View Between Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal 2015 Sep; 149(3):614-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26026393) Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015 Jun 01; 33(16):1825-34. View in: Jun 01; 33(16):1717-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25918284) [(18)F]-FLT predict to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot Nucl Med. 2015 Jul; 29(6):535-42. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25899481) Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS One. 2015; 10(3):e0120706. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25811460) Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. 2015 May-Jun; 65(3):167-89. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25683894) Diet survivors cancer. Clin North Am. 2015 Feb; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25475570) Post diagnosis diet quality and colorectal cancer survival in women. PLoS One. 2014; 9(12):e115377. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25506700) Relationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer. Abdom Imaging. 2014 Dec; 39(6):1261-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24906690) Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst. 2015 Jan; 107(1):345. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25432409) and features of signet-ring cell and mucinous components in colorectal and instability in relation to colorectal cancer prognosis. J Natl Cancer Inst. 2014 in colorectal cancer: with clinical, and molecular 2014 Dec; 21(13):4164-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25023548) Sugar-sweetened cancer survival 89803 (Alliance). PLoS One. 2014; associations of codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer. 2014 May 31; 13:135. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24885062) and pharmacodynamic 10; 32(14):1518-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24733800) Can we change the past for colorectal cancer patients and how do we move forward? Cancer. 2014 May 15; 120(10):1450-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24591002) Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. Inst. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24511107) Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014 Feb 20; 32(6):496-503. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24419123) Dose response to vitamin D in African Americans: results of a 4-arm, [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24368437) Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. J Natl Cancer Inst. 2013 Dec 04; 105(23):1789-98. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24231454) Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013 31(35):4465-70. Nov; 27(11):1088-90. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24575536) Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 2013 Aug 07; 105(15):1151-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23878352) Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer. 2013 Oct 15; 133(8):1905-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23580314) We are what we eat, are we? Clin Oncol. 2013 Aug colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014 Jun 05; 33(23):2949-55. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23792451) A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor. Cancer. 2013 Sep 01; 119(17):3212-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23733618) Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. J Clin Oncol. 2013 Jul 10; 31(20):2600-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23733765) cancer diagnosis: Effects of a 12-week home-based exercise program on the level of physical activity, insulin, and cytokines in colorectal cancer survivors: a pilot study. Support Care Cancer. 2013 Sep; 21(9):2537-45. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23636649) Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23580238) Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):508-16. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23462917) Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with \u00df-catenin (CTNNB1) status. Cancer Preoperative cetuximab, irinotecan, cisplatin, and advanced esophageal cancer. Oncologist. 2013; 18(3):281-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23429739) The effects of inpatient exercise therapy on the length of hospital stay in stages I-III colon cancer patients: randomized controlled trial. Int J Colorectal Dis. 2013 May; 28(5):643-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23417645) Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal and Cancer (TREC) initiative: rationale and design. Cancer Causes Control. 2013 Apr; 24(4):695-704. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23378138) The impact of glycemic advanced hepatocellular carcinoma: a phase II study. Res. 2013 plasma and survival in patients with colorectal cancer. Cancer Causes Control. 2013 Apr; 24(4):719-29. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23340905) Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23307060) Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors. Support Care Cancer. 2013 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23292698) Feasibility of 2013; 18(1):64-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23287880) The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status. Curr Colorectal Cancer [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24336119) Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23175808) Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23136358) use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012 Oct 25; 367(17):1596-606. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23094721) Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer. Colorectal Cancer. 2013 Mar; 12(1):62-9. lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg. 2012 Aug; 147(8):715-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22508672) Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. Eur J Cancer. 2012 Dec; 48(18):3405-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22840368) Prospective study of bevacizumab plus in patients with advanced neuroendocrine tumors. Oncol. 2012 Aug [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22778320) Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Clin Cancer Res. 2012 Sep 01; 18(17):4753-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22753589) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012 Aug; cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients cancer. PLoS One. 2012; 7(6):e38231. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22701615) Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012 Jul 20; 30(21):2624-34. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22665536) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012 Jul-Aug; 62(4):243-74. View colorectal cancer: cohort study and literature review. Clin Cancer Res. 2012 Apr 15; 18(8):2257-68. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22357840) Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Cancer Inst. 2012 Mar 07; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22312135) Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst. 2012 Feb 08; 104(3):211-27. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22266473) Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol. 2012 Feb 20; 30(6):608-15. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22253466) Stage III Colon Cancer: What Works, What Doesn't and Why, and What's Next. Am Soc Book. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22665454) Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012 Jun; Predictive and roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res. 2012 Feb 01; 18(3):890-900. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22147942) Energy in and energy out: matters for survivors of colorectal cancer? 2012 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22124098) Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting. Breast Cancer Res Treat. 2012 Feb; 132(1):205-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22113257) Tumor TP53 expression status, body mass index and prognosis in colorectal cancer. Int J Cancer. 2012 Sep 01; 131(5):1169-78. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22038927) Receptor tyrosine kinases exert over PI3K signaling in human KRAS mutant colorectal cancers. 6(9):e25062. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21949851) between statin use and colon cancer recurrence and survival: results from CALGB 89803. J 19; 103(20):1540-51. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21849660) Beyond standard adjuvant therapy for role interventions. Semin Oncol. 2011 Aug; 38(4):533-41. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21810512) Reported behavior of eating anything at anytime and risk of colorectal cancer in women. Int J Cancer. 2012 Mar 15; 130(6):1395-400. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21520042) Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol. 2011 Aug 20; 29(24):3255-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21768462) A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients. J Clin Oncol. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28022586) Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA. 2011 Apr 27; 305(16):1685-94. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21521850) Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer. 2011 Nov 15; 117(22):5094-102. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21538343) Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. of expression in 902 colorectal cancers: Cohort study and literature review. Int J Cancer. 2011 Mar 01; 128(5):1080-94. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20473920) A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric colorectal cancer, and prognosis: cohort study and literature review. J Pathol. 2010 Dec; 222(4):350-66. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20927778) Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers. Cancer. 2011 Apr 01; 117(7):1399-408. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21425139) Adjuvant therapy for stage II colon Adv Hematol Oncol. 2010 Nov; 8(11):772-4. prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic Aug; 68(2):293-300. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20960192) Dietary insulin insulin colorectal and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer. 2010 Sep 28; 103(7):1025-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20808308) Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. 28(28):4354-63. Host cancer 10; 28(26):4019-21. View View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20644082) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010 May; 176(5):2292-301. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20363910) Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer. 2010 Feb 15; 116(4):957-66. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20052723) New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient. Oncology (Williston Park). 2010 Jan; 24(1 Physical activity and male colorectal cancer survival. Arch Intern Med. 2009 Dec 14; 169(22):2102-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20008694) KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clin Cancer Res. 2009 Dec 01; Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet 2010 Jan; 11(1):48-54. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19903790) Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 2009 Oct 15; 15(20):6412-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19825961) Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol. 2010 Feb; 105(2):420-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19809407) Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2513-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19723919) Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5931-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19723652) Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. Oncol. 2009 View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19704056) Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15; 101(6):916-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19690551) A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous Nov; 137(5):1609-20.e1-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19686742) Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer. 2009 Aug 04; 101(3):465-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19603024) Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res. 2009 Jul 15; 15(14):4665-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19584150) A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res. 2009 Jul 01; 15(13):4431-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19549773) Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with findings from the bolus, Cancer. 2009 Jun 115(12):2617-29. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19382200) A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1849-58. sunitinib monotherapy in advanced hepatocellular carcinoma: a Oncol. 2009 Jun 20; 27(18):3027-35. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19470923) Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database. J Clin Oncol. 2009 May 20; 27(15_suppl):4010. fluorodeoxyglucose tomography (FDG-PET) study in patients with advanced biliary tract cancers (BTCs) receiving bevacizumab (B) in combination with gemcitabine (GEM) and oxaliplatin (OX). 27(15_suppl):4578. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27963071) KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27961543) Impact of age and comorbidities on treatment effect, tolerance, and toxicity in metastatic colorectal cancer (mCRC) patients treated results of multicenter phase II trial in patients with metastatic esophagogastric DNA methyltransferase and to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res. 2009 Jan 01; 15(1):338-45. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19118063) Plasma insulin-like and metastatic colorectal cancer: results from intergroup trial N9741. Dec 15; 14(24):8263-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19073970) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19047305) Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008 Dec phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009 Jan; 58(1):90-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18832519) DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18779600) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Oncol. Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol. 2008 Jul 01; 26(19):3222-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18591557) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008 Jun 20; 26(18):2984-91. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18565885) Comparing Safety and Efficacy of First-Line Irinotecan/Fluoropyrimidine Combinations in Elderly versus Nonelderly Patients with Metastatic Colorectal Cancer: Findings from the BICC-C Study. submitted. 2008. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008 Jun 04; 299(21):2515-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18523220) The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803. May [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27949293) Phase II study of RAD001 in previously treated patients with metastatic pancreatic cancer. Oncol. 2008 May 20; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27948463) Family history and survival after colorectal cancer diagnosis. Cancer. 2008 Mar 15; 112(6):1222-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18219663) Trends in island few methylated CpG islands, but also low-level methylation Pathol. 2008 Mar; 21(3):245-55. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18204436) The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803. . To be submitted. 2008. Phase II study of 2-methoxyestradiol (2ME2), administered in combination with bevacizumab, in patients (Pts) with advanced carcinoid tumors. Gastrointestinal Cancer Sympsosium. 2008. GI Cancers for the Boards. The Harvard Intensive Review of Internal Medicine (Ed: Singh A, Loscalzo J). 2008; In editorial stage.. The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803. Proc Am Soc Diagnostic Oncology (Ed: Skarin A). 2008; In editorial stage.. A phase II study of gemcitabine (GEM), bevacizumab (BEV), and erlotinib (E) in locally and metastatic adenocarcinoma (MPC) of the pancreas. Gastrointestinal Cancer Symposium. 2008. A phase II study of gemcitabine (G), bevacizumab (B), and erlotinib (E) in locally advanced (LAPC) and metastatic adenocarcinoma (MPC) of the pancreas. Proc Am Soc Clin Oncology. 2008. Phase II study of RAD001 in previously treated patients with metastatic pancreatic cancer. Proc Soc 20; 25(30):4787-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17947726) Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008 Jan; 134(1):21-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18005960) Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007 Aug 15; 298(7):754-64. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17699009) Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer. 110(3):581-9. 2007. A II study of docetaxel in combination with ZD1839 (gefitinib) in previously treated patients with metastatic pancreatic cancer. Proc Am Soc Clin Oncol. 2007. Phase study of gemcitabine, oxaliplatin in combination with bevacizumab (GEMOX-B) in patients or metastatic gallbladder cancers. Proc Am Clin Oncol. 2007. Prediction of response to temozolomide (TMZ)-based therapy by loss of MGMT expression in patients with advanced neuroendocrine tumors (NET). Proc Am Soc Clin Oncol. 2007. Correlation of beta-catenin localization with cyclooxygenase-2 expression CpG island patients with metastatic biliary and gallbladder Dig Dis Sci. 2008 Feb; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17597402) Phase II study of FOLFOX, erlotinib as first-line therapy for Oncol. Jul; 18(7):1185-9. View in: Adjuvant treatment J 2007 May-Jun; 57(3):168-85. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17507442) Adjuvant and neoadjuvant approaches in cancer. Cancer J. 2007 May-Jun; 13(3):168-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17620766) CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch. 2007 May; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17372756) Molecular correlates with MGMT silencing support CpG island methylator phenotype-low cancer. Gut. 2007 Nov; 56(11):1564-71. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17339237) Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007 Mar; 245(3):426-34. View in: Oct; 60(5):661-70. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17216531) A Prospective Study of Aspirin Dose and Duration of Use and Risk of Colorectal Cancer Among Men. Digestive Disease Week Convention. 2007. Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol. 2006 Dec Am J of / Oncology. 2006; 5(9):568-571. Phase I study of gefitinib plus FOLFIRI previously untreated patients with metastatic Cancer. 2006 Sep; 6(3):208-13. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17026790) Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J Clin Oncol. 2006 Aug 01; 24(22):3555-61. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16877721) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16822843) Physical and survival after cancer diagnosis. Clin Oncol. 2006 Aug 01; 24(22):3527-34. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16822844) Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. Cancer Chemother Pharmacol. 2007 Feb; 59(3):285-93. View in: Phase cetuximab with unresectable or metastatic hepatocellular study of FOLFOX, bevacizumab and erlotinib as initial therapy for patients with cancer A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors. Oncol. Jun 20; 24(18_suppl):4044. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27953648) Efficacy of cetuximab after oral epidermal factor receptor inhibitor-based study of capecitabine, and erlotinib in previously treated patients with Oncol. 2006 Apr 20; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16622264) A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors. Proc Am Soc Clin Oncol. 2006. Phase II study of bevacizumab and docetaxel (AvaTax) in metastatic esophageal and gastric cancer. Gastrointestinal Cancer Sympsosium. 2006. Phase II study of bevacizumab and docetaxel in metastatic esophageal and gastric cancer. Proc Am Soc Clin Oncol. 2006. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006 Jan; 19(1):59-68. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16118624) Aspirin Use and Survival after Diagnosis of Colorectal Cancer. Digestive Disease Week Convention. 2006. The overtreatment of patients with stage II disease [colon cancer]. ASCO News and Forum. 2006; 1(4):18-19. Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy. J Clin Oncol. 2005 Nov 20; 23(33):8453-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16293876) Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6650-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16166444) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005 Aug 24; 294(8):914-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16118381) Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB I of S-1 administrated for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer Clin Oncol. 2005 Jun; 23(16_suppl):4066. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27944174) The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer. J Med. 2005 Feb 03; 352(5):476-87. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15689586) Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803. Proc Am Soc Clin Oncol. 2005. and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors. Gastrointestinal Cancer Symposium. 2005. Epidermal growth factor receptor inhibitors and cancer. and erlotinib in previously treated patients with study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer. Oncol. Results Trial 2004 Relationship serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal Apr 15; 22(8):1439-46. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15084617) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J 15; 22(4):648-57. irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors. ESMO. 2004. Phase II study of docetaxel, cisplatin, and irinotecan (TPC) in advanced esophageal and gastric cancer. Proc Am Soc Clin Oncol. 2004. Phase II Cisplatin, Irinotecan, Celecoxib and Concurrent Radiation Therapy Followed by Surgery for Locally Advanced Esophageal Cancer. Gastrointestinal Cancer Symposium. 2004. Can an Optimal First-Line Therapy be Identified for Intergroup Trial N9741. Proc Am Soc Clin Oncol. 2004. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Oncol. 2004 Jan 01; 22(1):166-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/14701779) Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med. 2003 Oct 21; 139(8):649-57. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/14568853) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003 Aug 01; 98(3):484-95. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12879464) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12800796) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003 Feb 01; 21(3):433-40. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12560431) Gastric Cancer. Clinical Practice of Hematology and Oncology: Presentation, Diagnosis and Treatment (Ed: Mayer RJ, Furie B, Cassileth PA, and Atkins MB). 2003; 887-898. Adjuvant Therapy in Cancer: Can We Prevent Recurrences?. Oncology (Huntingt). Apr; 12(2):176-86. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11979419) Radiation 2002; 12:176-86. Truncated 2001 Feb; View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11232642) Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas. Cell Growth Differ. 1999 Jan; 10(1):35-42. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9950216) Identification and characterization of neogenin, gene. Oncogene. 1997 Mar 13; 14(10):1129-36. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9121761) Studies of a DCC-related protein and a candidate DCC ligand: The cloning and characterization of the human homologues of neogenin and netrin-1. 1997. The Role of the T Cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1994; 1:155-166. Tumor cell IL-6 gene expression is regulated by IL-1 alpha/beta and TNF alpha: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages. J Leukoc Biol. 1992 Oct; 52(4):463-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1402392) Transcription of the rat and mouse proenkephalin genes is initiated at distinct sites in spermatogenic and somatic cells. "}